Valion Bio (VBIO) Prepaid Assets (2021 - 2026)
Valion Bio (VBIO) posted Prepaid Assets of $524000.0 for Q2 2026, up 51.45% on a QoQ basis from $346000.0 in Q4 2025, and up 44.75% year-over-year from $362000.0 in Q2 2025.
Analysis
Valion Bio (VBIO) Prepaid Assets (2021 - 2026) Analysis & Trends
Valion Bio has reported Prepaid Assets for 6 years, with the latest figure at $524000.0 in Q2 2026.
- On a quarterly basis, Prepaid Assets rose 44.75% year-over-year to $524000.0 in Q2 2026; TTM through Jun 2026 was $524000.0, a 44.75% increase from a year earlier, with the FY2025 full-year figure at $346000.0, up 44.17% from the prior year.
- Prepaid Assets was $524000.0 for Q2 2026 at Valion Bio, up from $346000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $633000.0 in Q1 2022, with the low at $188000.0 in Q2 2024.
- Average Prepaid Assets over 5 years is $317882.4, with a median of $275000.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets plunged 70.37% in 2022, then jumped 92.55% in 2025.
- Over 5 years, Prepaid Assets stood at $235000.0 in 2022, then jumped by 39.15% to $327000.0 in 2023, then decreased by 26.61% to $240000.0 in 2024, then soared by 44.17% to $346000.0 in 2025, then surged by 51.45% to $524000.0 in 2026.
- The last three Prepaid Assets figures came in at $524000.0 (Q2 2026), $346000.0 (Q4 2025), and $267000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Valion Bio | 298,792.01 | -1.90 Mn | -45,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 524,000.00 |
| Dec 31, 2025 | 346,000.00 |
| Sep 30, 2025 | 267,000.00 |
| Jun 30, 2025 | 362,000.00 |
| Mar 31, 2025 | 273,000.00 |
| Dec 31, 2024 | 240,000.00 |
| Sep 30, 2024 | 234,000.00 |
| Jun 30, 2024 | 188,000.00 |
| Mar 31, 2024 | 250,000.00 |
| Dec 31, 2023 | 327,000.00 |
| Sep 30, 2023 | 227,000.00 |
| Jun 30, 2023 | 275,000.00 |
| Mar 31, 2023 | 294,000.00 |
| Dec 31, 2022 | 235,000.00 |
| Sep 30, 2022 | 331,000.00 |
| Jun 30, 2022 | 398,000.00 |
| Mar 31, 2022 | 633,000.00 |
| Dec 31, 2021 | 793,000.00 |